Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PSG Biotech is a global leader in providing specialized pump, sensor, and flow-control technologies for the life sciences and biopharmaceutical sectors. As a dedicated brand within PSG, a Dover company, it brings together industry-recognized brands including Quattroflow, Almatec, em-tec, and Malema. The company offers a comprehensive suite of fluid-handling solutions, ranging from quaternary diaphragm pumps to high-precision ultrasonic flow meters. These technologies are engineered to handle delicate biological fluids with low shear, ensuring product integrity during critical bioprocessing stages. PSG Biotech supports applications in vaccine production, cell and gene therapy, and monoclonal antibody manufacturing across both single-use and multi-use platforms. Their products are essential for downstream and upstream processing, providing the reliability required for commercial-scale biomanufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PSG Biotech.